CCI vs NTLA · P/E 40, rev $6.57B vs rev $57.9M
Crown Castle (CCI) versus Intellia Therapeutics Inc (NTLA) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported NTLA revenue for 2024-12-31 was $57.9M. Net income was -$519.0M. Revenue was up 59.6% from 2023-12-31 to 2024-12-31. NTLA currently screens at market cap $1.19B.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. NTLA currently screens at market cap $1.19B.
Not investment advice. Open the CCI and NTLA stock pages for the full models.
Not investment advice.